
AVTR — Avantor Inc
NYSE · Healthcare · Medical Instruments & Supplies
$14.73
+$0.53 (+3.73%)
Avantor Inc (AVTR) is a medical instruments & supplies company listed on NYSE. It is led by Michael Stubblefield, based in Radnor Corporate Center, Radnor, PA, United States, 19087, with about 13,500 employees. Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Latest reported AVTR revenue for 2025-09-30 was $1.62B. Net income was -$711.8M. Revenue was down 3.5% from 2025-06-30 to 2025-09-30. AVTR currently screens at market cap $9.36B and trailing P/E 13.3.
Use this AVTR page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the AVTR quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the AVTR SEC filings page. Lician reads the product cache first so this HTML stays unique to Avantor Inc even when a live quote feed is slow.
About Avantor Inc
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.
AVTR Key Statistics
Market Cap
$9.36B
Volume
5.56M
Previous Close
$14.26
Day Range
$14.05 – $14.50
P/E Ratio
13.26
EPS
$1.04
Revenue
$6.78B
Net Income
$711.50M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
-2.6%
Profit Margin
10.5%
Employees
13,500
AVTR Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $6.78B | $6.97B | $7.51B | $7.39B |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | $711.50M | $321.10M | $686.50M | $572.60M |
| EPS (Diluted) | $1.04 | $0.47 | $1.01 | $0.85 |
Total Assets
$12.11B
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$261.90M
Operating Cash Flow
$840.80M
Free Cash Flow
$0.00
Avantor Inc Company Information
- President, CEO & Director
- Michael Stubblefield
- Headquarters
- Radnor Corporate Center, Radnor, PA, United States, 19087
- Website
- www.avantorsciences.com
- Phone
- 610 386 1700
- IPO / Founded
- 2019-05-17
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies